10.30 (0.64%) Sun Pharmaceutical Industries has informed that the Board of Directors of the Company, at its meeting scheduled to be held on Monday, January 31, 2022, will consider declaration of Interim Dividend on the equity shares of the Company, for the financial year 2021-22.
The above information is a part of company’s filings submitted to BSE.